Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 9/20 | 0.56 |
| ▸ | BRAF | P15056 | 10/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | RAF1 | P04049 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19233576 | 0.86 | BRAF (0.59) | KDRBRAFNPC1POLBHTT | |
| SCHEMBL20577750 | 0.83 | KDR (0.50) | KDRBRAFCYP2C9 | |
| SCHEMBL20577950 | 0.81 | PTGS1 (0.56) | KDRBRAFCYP2C9 | |
| SCHEMBL20577764 | 0.80 | KDR (0.54) | KDRBRAFCYP2C9RAF1 | |
| SCHEMBL26075765 | 0.78 | BRAF (0.54) | BRAFCYP2C9RAF1 | |
| SCHEMBL1698051 | 0.78 | KDR (0.53) | KDRBRAFCYP2C9RAF1 | |
| SCHEMBL26075623 | 0.77 | BRAF (0.57) | KDRBRAFCYP2C9 | |
| SCHEMBL26075773 | 0.76 | BRAF (0.53) | KDRBRAFCYP2C9 | |
| SCHEMBL5004766 | 0.75 | BRAF (0.59) | BRAFCYP2C9 | |
| SCHEMBL2856788 | 0.74 | BRAF (0.51) | KDRBRAFCYP2C9RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017135589-A9 | PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | 삼진제약주식회사 | 2017-10-19 | — | — | WO | disclosed |
| WO-2017135589-A1 | PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF | 삼진제약주식회사 | 2017-08-10 | — | — | WO | disclosed |